Congresses and Meetings

It’s the 2014 Combined Otolaryngology Spring Meetings (COSM) in Las Vegas this week, and event that has seen the presentation of new data on the SinuSys™ the Vent-Os™ Sinus Dilation System. Six month clinical study results demonstrated sustained patency of the maxillary sinus ostia at six months.

It’s six months since we heard from Miracor Medical Systems about progress with its PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) System. Now the company has announced that clinical study data will be presented from the podium at “EuroPCR.”

A new “swallowable” GI imaging device device has the potential to safely produce high-resolution images of the colon without requiring patients to go through the bowel cleansing process beforehand, says data presented at a research forum during DDW2014.

Veryan Medical’s MIMICS study of its 3D helical vascular stent has reached the two year point and will see results presented at the 15th Annual New Cardiovascular Horizons (NCVH) Conference taking place between May 28th and 30th in New Orleans.

In a new study, St.Jude’s Quadripolar left ventricular pacing system demonstrated 53% reduction in hospitalization translating into 62% overall cost reduction compared with its non-Quadripolar system.

New retrospective data presented at the World Institute of Pain (WIP) 7th World Congress demonstrates that Boston Scientific’s Precision Spectra™ Spinal Cord Stimulator (SCS) System provided sustained and highly significant relief of low-back pain six months after implantation.

Medigus Ltd., a medical device company developing minimally-invasive, endosurgical tools and procedures, points us at two presentations at last week’s Digestive Disease® Week annual meeting, involving the use of its MUSE™ System for transoral fundoplication.

St. Jude Medical, Inc., has announced results of the TOCCASTAR clinical trial, the first prospective, randomized study of contact-force ablation technology for the treatment of paroxysmal atrial fibrillation (AF). The trial met its primary endpoints and supplements the growing body of evidence that supports the safety and effectiveness of contact-force ablation technology.

GI Dynamics is trumpeting new data from a study performed with GlaxoSmithKline, presented at Digestive Disease Week 2014 (DDW). Bile Acid increases, as experienced with Roux-en-Y Gastric Bypass, may explain weight loss and glucose stabilization,

Edwards Lifesciences has used the AATS Annual Meeting to trumpet three-year clinical outcomes of its EDWARDS INTUITY valve platform which demonstrated improved cardiac and valvular performance, as well as patient functional status compared with the standard valve equivalent.

PROCEED II heart transplant FDA pivotal trial results using the Organ Care System (OCS™) Heart platform have been presented at the International Society for Heart and Lung Transplantation (ISHLT) 34th Annual Meeting and Scientific Sessions in San Diego, California.

A pooled analysis study of the Parachute, first-of-its-kind catheter-based treatment for heart failure has been presented at ACC 2014 and the results look encouraging, with left ventricular volume reduction and heart function improvement.

DePuy Synthes Power Tools has launched its “Next Generation”, 30% more powerful electric drill system for neurosurgery, otology and spinal procedures.

An update on breakthroughs in artificial vision research into the use of subretinal implants in the treatment of Retinitis Pignentosa, was presented at the weekend’s World Ophthalmology Congress in Japan.

While Edwards Lifesciences and Medtronic slugged it out at ACC 2014 with studies comparing their TAVI (transcatheter aortic valve implantation)offerings, Boston Scientific draws our attention to new data presented at the event that says its own Lotus™ Valve System continued to demonstrate impressive performance at three months.

Presented at ACC 2014 is the first prospective, randomized study to compare transcatheter aortic valve replacement with open heart surgery in high risk patients. TAVR wins.